Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2047-9158

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease ; volume:5 ; number:1 ; day:29 ; month:11 ; year:2016 ; pages:1-6 ; date:12.2016
Translational neurodegeneration ; 5, Heft 1 (29.11.2016), 1-6, 12.2016

Classification: Biowissenschaften, Biologie

Creator: Zhang, Bei

Contributor: Li, Qiongqiong
Chu, Xingkun
Sun, Suya
Chen, Shengdi
SpringerLink (Online service)

DOI: 10.1186/s40035-016-0068-y

URN: urn:nbn:de:1111-201701146389

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Zhang, Bei
Li, Qiongqiong
Chu, Xingkun
Sun, Suya
Chen, Shengdi
SpringerLink (Online service)

Other Objects (12)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer’s disease models

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Propagation of Tau pathology in Alzheimer disease

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer’s disease models

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Propagation of Tau pathology in Alzheimer disease

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer’s disease models

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Propagation of Tau pathology in Alzheimer disease

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer’s disease models

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Propagation of Tau pathology in Alzheimer disease

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer’s disease models

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Propagation of Tau pathology in Alzheimer disease

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer’s disease models

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Propagation of Tau pathology in Alzheimer disease

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Related objects

Reset password